Rumored Buzz on Healthcare News
FTC sues significant pharmacy advantage managers over insulin price ranges The company brought action from Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing cost of existence-conserving insulin drugs.This plan aligns with These attempts, the ONC said. The